Tigermed ESMO 2026 Seminar & Reception
An exclusive evening of oncology insights, global perspectives, cocktails, and meaningful connections with industry leaders.
Join Tigermed during ESMO 2026 for an evening where insights, connections, and culture come together.
This event is primarily designed for professionals from pharmaceutical and biotechnology companies. Space is limited, and registrations from CROs, CDMOs and other service providers will be subject to confirmation.
Explore the latest perspectives on MRCT and global clinical development, with a focus on the opportunities and considerations for European biopharma companies navigating cross-border development and access to China. Gain a closer look at China’s evolving clinical research landscape, including the new regulatory framework for biomedical technologies under State Council Order No. 818, and what these developments could mean for innovative therapies and Europe-China clinical collaboration.
After the seminar, unwind over cocktails and refreshments, connect with industry peers and Tigermed experts from across Europe and other global markets, and enjoy a special Flamenco performance in the heart of Madrid.
What to expect:
• Insights on MRCT and global clinical development
• Perspectives on China’s evolving clinical research landscape
• Considerations for Europe-China clinical development and collaboration
• Networking with pharma, biotech and clinical development leaders
• Cocktails & refreshments
• Live Flamenco performance
Come for the insights. Stay for the connections—and enjoy the evening in Madrid.
Good to know
Highlights
- 3 hours 30 minutes
- In person
Location
Rosewood Villa Magna, Paseo de la Castellana, 22 – 28046 Madrid, Spain
Rosewood Villa Magna
Paseo de la Castellana 22 – 28046 Madrid
How do you want to get there?

Agenda
-
Welcome & Opening Remarks
Welcome remarks and an introduction to the evening’s program.
-
The Landscape of China's Anti-tumor Clinical Trials
Insights on integrating China into global multi-regional clinical trials and unlocking greater value in global clinical development.
-
Navigating China's Regulatory Pathways for Global Clinical Development
From Development Strategies to Local Trial Partnerships in Europe